Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Tian-Qiang Song
Observed names:
T. Song,
TianQiang Song,
Tian‐Qiang Song
Institutions:
Tianjin Medical University Cancer Institute and Hospital,
Tianjin Medical University
Observed institutions:
Second Military Medical University,
Fudan University,
Tianjin Medical University Cancer Institute and Hospital,
Zhongshan Hospital,
Eastern Hepatobiliary Surgery Hospital,
Guangdong Provincial People's Hospital,
Tianjin Medical University
show all 7
ORCID:
0000-0002-6510-0489
Observed ORCIDs:
0000-0002-6510-0489,
0000-0002-8710-6339
OpenAlex ID:
A5103230780
Randomized Controlled Trial of the Prophylactic Effect of Urea-Based Cream on Sorafenib-Associated Hand-Foot Skin Reactions in Patients With Advanced Hepatocellular Carcinoma
2015
·
ZhengGang Ren
, KangShun Zhu
, et al.
·
Journal of Clinical Oncology
·
161
PDF
Neutrophil–lymphocyte ratio as a predictor of outcomes for patients with hepatocellular carcinoma undergoing TAE combined with Sorafenib
2014
·
Kai Wei
, Meng Wang
, et al.
·
Medical Oncology
·
33
Shanghai Score: A Prognostic and Adjuvant Treatment-evaluating System Constructed for Chinese Patients with Hepatocellular Carcinoma after Curative Resection
2017
·
Hui-Chuan Sun
, Lu Xie
, et al.
·
Chinese Medical Journal
·
31
Comparison of Liver Transplantation and Liver Resection for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus Type I and Type II
2020
·
Jia-Yu Lv
, Ning-Ning Zhang
, et al.
·
Yonsei Medical Journal
·
24
PDF
Pemigatinib in previously treated Chinese patients with locally advanced or metastatic cholangiocarcinoma carrying FGFR2 fusions or rearrangements: A phase II study
2022
·
Guo‐Ming Shi
, Xiao‐Yong Huang
, et al.
·
Cancer Medicine
·
23
PDF
Donafenib and sintilimab combined with hepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma: a prospective, single-arm phase II trial (DoHAICs study)
2025
·
Wei Gao
, Zhao-Long Pan
, et al.
·
EClinicalMedicine
·
20
PDF
Liver resection after atezolizumab and bevacizumab versus maintenance therapy for locally advanced hepatocellular carcinoma (TALENTOP): a multicentre, open-label, randomised, phase 3 trial
2026
·
Hui-Chuan Sun
, Xiao-Dong Zhu
, et al.
·
The Lancet
·
9
Deep learning-assisted tumor radiomic dynamics on MRI predict pathological complete response in HCC undergoing immune-based therapy followed by hepatectomy
2026
·
Shi-Qi Zhou
, Lu-Na Wang
, et al.
·
Hepatology
·
7
Individualised tailored assessment of therapeutic alternatives for HCC patients within the Milan criteria
2019
·
Ningning Zhang
, Wentao Jiang
, et al.
·
Gut
·
5
PDF
Supplemental Material for: Integrating MRI-Based Deep Learning and Radiomics to Predict Treatment Response in Hepatocellular Carcinoma Receiving Combined Systemic and Locoregional Therapies: A Multicenter Study
2026
·
figshare admin karger
, Lu-Na Wang
, et al.
·
Figshare
Integrating Magnetic Resonance Imaging-Based Deep Learning and Radiomics to Predict Treatment Response in Hepatocellular Carcinoma Receiving Combined Systemic and Locoregional Therapies: A Multicenter Study
2026
·
Lu-Na Wang
, Shi-Qi Zhou
, et al.
·
Liver Cancer
PDF
Robotic Radiosurgical Stereotactic Body Radiation Therapy for Liver Metastases
2012
·
Z. Yuan
, C. Liu
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
Show more works
View as search
Works count:
12
Citation count:
313
H-index:
7
I10-index:
6
Year
Topic
Type